| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |